Reuters Health Information: Liver injury from herbals and dietary supplements may be rising in some parts of US
Liver injury from herbals and dietary supplements may be rising in some parts of US
Last Updated: 2014-09-22
By Will Boggs MD
NEW YORK (Reuters Health) - Liver injury from herbal
medicines and dietary supplements appears to be on the rise in
some parts of the country, according to data from the U.S.
Drug-Induced Liver Injury Network (DILIN).
"More research is needed to identify more accurately what
supplements, or ingredients thereof, cause liver injury and
why," Dr. Victor J. Navarro from Einstein Medical Center in
Philadelphia told Reuters Health by email. "Also, regulators
must take note that current regulation of dietary supplements
leans more toward protection of the manufacturer than the
consumer."
About half of the U.S. adult population say they use herbals
and dietary supplements, and there have been recent cases of
life-threatening hepatotoxicity associated with the use of at
least one of them (OxyElite Pro).
Dr. Navarro and colleagues examined the burden and
characteristics of liver damage attributed to these products in
the DILIN and compared the injuries with those caused by
conventional medications. They excluded all cases related to
acetaminophen, which account for the vast majority of
medication-induced liver injuries.
The researchers defined liver injury as jaundice or
coagulopathy in the presence of liver enzyme abnormalities or
elevations of ALT or AST above five times the upper limit of
normal or elevations of alkaline phosphatase above two times the
upper limit of normal on two consecutive measurements at least
24 hours apart.
As for causality, medications were considered individually,
whereas all herbals and dietary supplements taken by any patient
were grouped together and adjudicated as a single agent, even if
several were taken concurrently.
Ultimately, the analysis included 839 patients whose
"definite," "very likely," or "probable" liver injuries were
reported in the 10 years between 2004 and 2013. Most of these
injuries (85%) were attributed to medications, and the rest were
chalked up to herbals or dietary supplements.
The researchers divided those taking herbals and supplements
into two groups based on whether they took the substances for
bodybuilding purposes (45/130) or not (85/130).
During the first two years, cases attributed to herbals and
dietary supplements accounted for 7% (eight cases) of the
non-acetaminophen liver injuries. By the end of the study
period, they accounted for 20% (63 cases in three years).
Liver transplantation was required more commonly in the
nonbodybuilding supplements group (13%, 12 cases) than in the
medications group (3%, 21 cases).
Based on the DILIN severity score, people taking herbals and
dietary supplements had more severe cases than did those on
conventional medications, the researchers report in Hepatology,
online August 25.
The 130 patients in the herbals and dietary supplements
group reported taking a total of 217 products, with only a
minority of those products having a single ingredient and with
10% (bodybuilding) to 13% (nonbodybuilding) of the products
containing more than 20 ingredients.
"Contrary to widespread belief, this study demonstrates that
herbals and dietary supplement products are not always safe,"
the researchers conclude. "Indeed, our data suggest that,
relative to conventional medication-induced hepatotoxicity,
liver injury from herbal and dietary supplements not only
occurs, but also may be increasing in frequency over time in the
populations surrounding the DILIN centers and, probably, in the
United States as a whole."
"The DILIN is not a population-based study, and although
there was an increasing proportion of disease attributable to
herbals and dietary supplements during the study, it cannot be
concluded that the problem is actually on the rise in the United
States," they add.
"Ask patients if they use supplements and always suspect
them to be a cause for any unusual presentation, liver disease
or otherwise," Dr. Navarro concluded.
How can patients protect themselves from supplement-related
liver injury? "First, discuss their use with a qualified
physician who understands their specific medical history and has
knowledge of their other medications," Dr. Navarro
suggested. "Second, if they choose to use supplements, they
should stay within the labeled recommendations. Last, they
should report any new symptoms to their doctor."
Dr. Rolf Teschke from Goethe University Frankfurt/Main in
Germany, who studies medication-related liver toxicity, said
most herbals and dietary supplements carry some risk of liver
toxicity.
The risk is small but unpredictable, he told Reuters Health
by email, and may be related to genetic susceptibility.
"Physicians often are confronted with patients who have
increased liver values of primarily unknown etiology," Dr.
Teschke said. "Apart from questioning regarding synthetic drugs
as possible cause, the use of herbals and dietary supplements
should be excluded by thorough investigation and repetitive
questionings, since they are considered as natural and thereby
perceived erroneously as safe."
He also criticized DILIN's causality assessments for not
being quantitative.
"Other experts in the field worldwide prefer the use of the
scale of CIOMS (Council for International Organizations of
Medical Sciences), which is liver specific, structured, and
quantitative based on specific items which are individually
scored by -3 to +3 points, while the sum of the individual
scores provides the respective causality grading," Dr. Teschke
said. "The CIOMS scale can easily be applied already at the
bedside of the patient, with results quickly available without
the time-consuming expert-based procedure."
"Herbal and dietary supplements commonly are mixtures of
multiple ingredients which prevent a clear causality assessment
to one single ingredient," Dr. Teschke said. "The DILIN method
is not prepared assessing various comedicated compounds, as
opposed to the CIOMS scale, which facilitates such assessment."
SOURCE: http://bit.ly/XNJwxK
Hepatology 2014.
|